Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.01
+0.27 (3.49%)
Apr 8, 2026, 3:55 PM EDT - Market open
Solid Biosciences Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$16.36
Upside
+104.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +49.81% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +149.69% | Mar 23, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +224.59% | Mar 20, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +87.27% | Mar 20, 2026 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +137.20% | Mar 20, 2026 |
| Wedbush | Wedbush | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +112.23% | Mar 12, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +87.27% | Mar 12, 2026 |
| Wedbush | Wedbush | Buy Reiterates $14 | Buy | Reiterates | $14 | +74.78% | Mar 11, 2026 |
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +99.75% | Feb 9, 2026 |
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +99.75% | Jan 14, 2026 |
| Needham | Needham | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +99.75% | Dec 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +74.78% | Nov 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +37.33% | Nov 5, 2025 |
| Barclays | Barclays | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +12.36% | Nov 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +87.27% | Nov 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +87.27% | Aug 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.